# Recce Pharmaceuticals

Type: Company (RCE.AX)

Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/recce-pharmaceuticals
Canonical HTML page: https://getstartupbrief.com/entity/recce-pharmaceuticals

## Recent coverage (1 stories)

### Recce Pharmaceuticals Secures Brazilian Patent for Anti-Infective Platform
2026-03-24 03:24:48 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Recce Pharmaceuticals has received a patent grant in Brazil for its synthetic anti-infective platform, marking a significant expansion of its intellectual property portfolio in South America. This move strengthens the company's global position in the fight against antimicrobial resistance (AMR), a critical challenge for modern healthcare.
Full story: https://getstartupbrief.com/story/recce-pharmaceuticals-brazil-patent-anti-infective

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.